Roger D. Kornberg
Tracked across 1 events · 6 articles · First seen Aug 17, 2026 · Last active Aug 17, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Cocrystal Pharma, Inc., a clinical-stage biotechnology company developing antiviral therapeutics, announced the appointment of Carol Brosgart, MD to its Board of Directors, effective August 12, 2026. Dr. Brosgart brings decades of experience in antiviral therapy,…
Impact: Roger D. Kornberg, as Chairman and Chief Scientist, welcomed Brosgart's appointment, emphasizing her value to Cocrystal's clinical development efforts.
Aug 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Roger D. Kornberg live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard